These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36648782)

  • 1. Concordance of Clinical, Histologic and Direct Immunofluorescence Findings in Patients with Autoimmune Bullous Dermatoses in Vietnam.
    Tran GH; Le NTA; Dang MH; Doan TTP; Phung TL
    Dermatopathology (Basel); 2023 Jan; 10(1):30-40. PubMed ID: 36648782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic significance of immunofluorescent tests in dermatology].
    Medenica L; Skiljević D
    Med Pregl; 2009; 62(11-12):539-46. PubMed ID: 20491380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Triaging Direct Immunofluorescence in Intraepidermal Bullous Dermatoses.
    Tjarks BJ; Billings SD; Ko JS
    Am J Dermatopathol; 2018 Jan; 40(1):24-29. PubMed ID: 28368874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Direct Immunofluorescence in Cutaneous Autoimmune Bullous Disorders.
    Brar A; Sharma A; Nauhria S; Nauhria S; Bhattacharjee A; Peela J; Joshi K
    Cureus; 2021 Apr; 13(4):e14562. PubMed ID: 34026378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of direct immunofluorescence in dermatological disorders.
    Mysorekar VV; Sumathy TK; Shyam Prasad AL
    Indian Dermatol Online J; 2015; 6(3):172-80. PubMed ID: 26009711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
    Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
    Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cross-sectional Study of Direct Immunofluorescence in the Diagnosis of Immunobullous Dermatoses.
    Buch AC; Kumar H; Panicker N; Misal S; Sharma Y; Gore CR
    Indian J Dermatol; 2014 Jul; 59(4):364-8. PubMed ID: 25071256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of histopathologic findings in pemphigoid: Avoiding diagnostic pitfalls.
    Hodge BD; Roach J; Reserva JL; Patel T; Googe A; Schulmeier J; Brodell RT
    J Cutan Pathol; 2018 Nov; 45(11):831-838. PubMed ID: 30141231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
    Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
    Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous autoimmune dermatoses.
    Hofmann SC; Juratli HA; Eming R
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1339-1358. PubMed ID: 30395395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study.
    Sernicola A; Russo I; Saponeri A; Alaibac M
    Medicine (Baltimore); 2019 Feb; 98(7):e14514. PubMed ID: 30762788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Value of Type IV Collagen Immunohistochemical Staining in the Differential Diagnosis of Autoimmune Subepidermal Bullous Diseases.
    Yeol Lee H; Ham SP; Choi YW; Park HJ
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):133-138. PubMed ID: 29989869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid.
    Glauser S; Rutz M; Cazzaniga S; Hegyi I; Borradori L; Beltraminelli H
    Br J Dermatol; 2016 Nov; 175(5):988-993. PubMed ID: 27105821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of autoimmune bullous diseases in Iran: a 10-year review.
    Daneshpazhooh M; Chams-Davatchi C; Payandemehr P; Nassiri S; Valikhani M; Safai-Naraghi Z
    Int J Dermatol; 2012 Jan; 51(1):35-41. PubMed ID: 22182376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous tinea pedis with direct immunofluorescence positivity: when is a positive result not autoimmune bullous disease?
    Miller DD; Bhawan J
    Am J Dermatopathol; 2013 Jul; 35(5):587-94. PubMed ID: 22892469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study.
    Arunprasath P; Rai R; Venkataswamy C
    Indian Dermatol Online J; 2020; 11(6):915-919. PubMed ID: 33344339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Analysis of BIOCHIP Mosaic-based Indirect Immunofluorescence with Direct Immunofluorescence in Diagnosis of Autoimmune Bullous Diseases: A Cross-Sectional Study.
    Arunprasath P; Rai R; Venkataswamy C
    Indian Dermatol Online J; 2021; 12(1):105-109. PubMed ID: 33768030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and acquired blistering disorders of pediatric age group: An experience from Eastern India.
    Karmakar S; Basu K; Sengupta M; Chatterjee G; Sarkar S; Bandopadhyay M
    Indian J Pathol Microbiol; 2021; 64(3):509-517. PubMed ID: 34341262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptualization and validation of an innovative direct immunofluorescence technique utilizing fluorescein conjugate against IgG + IgG4 for routinely diagnosing autoimmune bullous dermatoses.
    Jałowska MD; Gornowicz-Porowska J; Seraszek-Jaros A; Bowszyc-Dmochowska M; Kaczmarek E; Dmochowski M
    Cent Eur J Immunol; 2021; 46(2):183-190. PubMed ID: 34764786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.